“If this works the way we think it’s going to work, it will change medical practice”

In this episode of CM Conversations, it's the turn of imaging specialist and Business Manager Cameron Ramsden. He spoke with Bob Proulx, Chairman and CEO of Imagion Biosystems. Imagion are blazing a trail in the world of imaging with their fascinating technology, which utilises nanoparticles to help detect cancer with better specificity and sensitivity, without exposure to radiation. They covered the technology, what it's like to be classed as an FDA 'breakthrough' device and what the future holds for Imagion and the imaging market in general. If you'd like to get involved in the conversation, email us at [email protected] Cameron on LinkedIn hereFollow Bob on LinkedIn here Hosted on Acast. See acast.com/privacy for more information.